Aspen pharmaceutical firm infringes the arrangement with NHS
Independent - 03-Oct-2019Monopolist Aspen got the opportunity to raise the price of essential NHS medicine by 1,800 per cent
Join the club for FREE to access the whole archive and other member benefits.
Company focused on a broad range of post-patent, branded medicines, and domestic brands spanning many therapeutic areas
As a leading global player in specialty, branded and generic pharmaceuticals, we have an extensive basket of products that provide treatment for a broad spectrum of acute and chronic conditions experienced through all stages of life. We continue to increase the number of lives benefiting from our products that reach more than 150 countries. In line with the our commercial, production and territorial strategies, we have identified Thrombosis, Anaesthetics, High Potency & Cytotoxics as our focused therapeutic categories that will receive our highest focus based on materiality and future potential.
Visit website: https://www.aspenpharma.com/
Details last updated 22-Oct-2019
Monopolist Aspen got the opportunity to raise the price of essential NHS medicine by 1,800 per cent